Department of Anesthesia, Royal Victoria Hospital, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada.
Department of Critical Care Medicine, Royal Victoria Hospital, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada.
Crit Care. 2018 Jan 25;22(1):14. doi: 10.1186/s13054-017-1928-2.
The incidence of delayed graft function in patients undergoing kidney transplantation remains significant. Optimal fluid therapy has been shown to decrease delayed graft function after renal transplantation. Traditionally, the perioperative volume infusion regimen in this patient population has been guided by central venous pressure as an estimation of the patient's volume status and mean arterial pressure, but this is based on sparse evidence from mostly retrospective observational studies. Excessive volume infusion to the point of no further fluid responsiveness can damage the endothelial glycocalyx and is no longer considered to be the best approach. However, achievement of adequate flow to maintain sufficient tissue perfusion without maximization of cardiac filling remains a challenge. Novel minimally invasive technologies seem to reliably assess volume responsiveness, heart function and perfusion adequacy. Prospective comparative clinical studies are required to better understand the use of dynamic analyses of flow parameters for adequate fluid management in kidney transplant recipients. We review perioperative fluid assessment techniques and discuss conventional and novel monitoring strategies in the kidney transplant recipient.
在接受肾移植的患者中,移植肾功能延迟恢复的发生率仍然很高。研究表明,优化液体治疗可降低肾移植后移植肾功能延迟恢复的发生率。传统上,该患者人群的围手术期容量输注方案以中心静脉压作为患者容量状态和平均动脉压的估计值,但这主要基于来自大多回顾性观察性研究的稀疏证据。过量的容量输注到没有进一步的液体反应性的程度会损害内皮糖萼,不再被认为是最佳方法。然而,实现足够的血流以维持足够的组织灌注而不最大限度地充盈心脏仍然是一个挑战。新型微创技术似乎可以可靠地评估容量反应性、心功能和灌注充足性。需要前瞻性的比较临床研究来更好地了解使用流量参数的动态分析来对肾移植受者进行适当的液体管理。我们回顾了围手术期液体评估技术,并讨论了肾移植受者的传统和新型监测策略。